Cited 1 time in
Cited 2 time in
Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease
- Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease
- Jang, Han Nah; Kim, Se Hwan; Lee, Jae Man; Oh, Yong Seok; Park, Sang Myun; Kim, Sang Ryong
- DGIST Authors
- Oh, Yong Seok
- Issue Date
- NeuroReport, 28(5), 242-249
- Article Type
- Article in Press
- 6-Hydroxydopamine; Montelukast; Neuroinflammation; Neuroprotection
- Although the main cause of degeneration of the nigrostriatal dopaminergic (DA) projection in Parkinson's disease (PD) is still controversial, many reports suggest that excessive inflammatory responses mediated by activated microglia can induce neurotoxicity in the nigrostriatal DA system in vivo. Montelukast, which plays an anti-inflammatory role, is used to treat patients with asthma. In addition, recent studies have reported that its administration could reduce neuroinflammatory activities, showing beneficial effects against various neuropathological conditions. These results suggest that montelukast may be a useful drug to alleviate inflammatory responses in PD, even though there are no reports showing its beneficial effects against neurotoxicity in the nigrostriatal DA system. In the present study, our results showed that treatment with montelukast could protect DA neurons against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity and its administration significantly attenuated the production of neurotoxic cytokines such as tumor necrosis factor-α (TNFα) and interleukin-1β (IL-1β) from activated microglia in the substantia nigra (SN) and striatum following 6-OHDA treatment. Therefore, we suggest that montelukast can be used as a potential inhibitor of microglial activation to protect DA neurons in the adult brain against PD. © 2017 Wolters Kluwer Health, Inc. All rights reserved.
- Lippincott Williams and Wilkins
- Related Researcher
Laboratory of Neural Signaling Networks
Monoaminergic regulation of the CNS and mood;anxiety disorder; 모노아민 (세로토닌, 도파민)에 의한 신경조절과 기분;불안 장애 기전 연구
There are no files associated with this item.
- Department of Brain and Cognitive SciencesLaboratory of Neural Signaling Networks1. Journal Articles
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.